168
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Higher Stage in Urothelial Carcinoma

ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 615-621 | Published online: 15 Feb 2022

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
  • Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447–461. doi:10.1016/j.eururo.2016.05.041
  • Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523–1525. doi:10.1016/S0022-5347(05)67019-X
  • Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–1233. doi:10.1002/cncr.24135
  • Rouprêt M, Babjuk M, Burger M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62–79. doi:10.1016/j.eururo.2020.05.042
  • Lane BR, Smith AK, Larson BT, et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer. 2010;116(12):2967–2973. doi:10.1002/cncr.25043
  • Su X, Han H, Li X, et al. Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma. Oncotarget. 2017;8(16):26106–26111. doi:10.18632/oncotarget.15344
  • Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868–879. doi:10.1016/j.eururo.2015.06.044
  • Liu Z, Zheng S, Li X, et al. Oncologic outcomes of patients undergoing diagnostic ureteroscopy before radical nephroureterectomy for upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A. 2018;28:1316–1325. doi:10.1089/lap.2018.0015
  • You M, Li H, Gao Y, et al. Clinical application value of FH/ROS combined test in cervical cancer screening. Hans J Biomed. 2019;9(4):5. doi:10.12677/HJBM.2019.94022
  • Mbeutcha A, Rouprêt M, Kamat AM, et al. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J Urol. 2017;35(3):337–353. doi:10.1007/s00345-016-1826-2
  • Bourgade V, Drouin SJ, Yates DR, et al. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World J Urol. 2014;32(2):475–479. doi:10.1007/s00345-013-1045-z
  • Buteau A, Seideman CA, Svatek RS. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol. 2014;32(2):128–134. doi:10.1016/j.urolonc.2012.07.001
  • Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey. Urol Oncol Semin Original Investig. 2010;28(5):500–503. doi:10.1016/j.urolonc.2008.10.018
  • Johnson EK, Daignault S, Zhang Y, et al. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology. 2008;72(3):498–502;discussion 502–3. doi:10.1016/j.urology.2008.01.086
  • Tamalunas A, Volz Y, Schlenker BA, et al. Is it safe to offer radical cystectomy to patients above 85 years of age? A long-term follow-up in a single-center institution. Urol Int. 2020;104(11–12):975–981. doi:10.1159/000510137
  • Wang Z, Wang G, Xia Q, et al. Partial nephrectomy vs. radical nephrectomy for renal tumors: a meta-analysis of renal function and cardiovascular outcomes. Urol Oncol. 2016;34(12):533.e11–533.e19. doi:10.1016/j.urolonc.2016.07.007
  • Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011;108:701–705. doi:10.1111/j.1464-410X.2010.09899.x
  • Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31(7):1166–1170. doi:10.1016/j.urolonc.2011.12.021
  • Guo RQ, Hong P, Xiong GY, et al. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int. 2018;121(2):184–193. doi:10.1111/bju.14053
  • Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol. 2007;8(9):722–728. doi:10.1038/nrm2240
  • Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–950. doi:10.1152/physrev.00026.2013
  • Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous Liason in cancer cells. Cell Death Dis. 2016;7:e2253. doi:10.1038/cddis.2016.105
  • O’Quinn RL, Fishbein M. Isolation, characterization and cross-species amplification of polymorphic microsatellite loci in Asclepias (Apocynaceae). Conservat Genet. 2009;10(5):1437–1440. doi:10.1007/s10592-008-9755-2
  • Qi N, Zhang J, Chen Y, Wen R, Li H. Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma. Cancer Manag Res. 2018;10:4929–4933. doi:10.2147/CMAR.S180606
  • Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–786. doi:10.1111/bju.13345
  • Tamalunas A, Buchner A, Kretschmer A, et al. Impact of routine laboratory parameters in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: a long-term follow-up. Urol Int. 2020;104(7–8):551–558. doi:10.1159/000506263